Inhibition of PAK1, the primary downstream target of Rac1 [49] responsible for vimentin Ser38 phosphorylation [40, 50] greatly reduced metastasis (Fig. 7), highlighting a promising potential for developing drugs targeting this function for cancer treatment. This evidence concerns the gene VIM and cancer.